Daniel R. Kuritzkes, MD is Professor of Medicine at Harvard Medical School and Director of AIDS Research, Brigham & Women's Hospital in Boston.  He is Head of the Section of Retroviral Therapeutics for the Harvard Division of AIDS. Dr. Kuritzkes also serves as Vice Chair of the Executive Committee of the Adult AIDS Clinical Trials Group (ACTG) and is the Principal Investigator of the Harvard Adult AIDS Clinical Trials Unit. Dr. Kuritzkes' research interests include the mechanisms contributing to the selection and evolution of resistance to all classes of antiretroviral drugs as well as exploring the fitness of the resulting resistant mutant viral populations and its effect upon disease progression.

Charles Flexner, MD, is Professor of Medicine in the Divisions of Clinical Pharmacology  and Infectious Diseases, and Professor of Pharmacology and Molecular Sciences at  the Johns Hopkins University School of Medicine in Baltimore. In addition, Dr. Flexner is Professor of International Health (Bloomberg School of Public Health). He is Principal Investigator for the Johns Hopkins University AIDS Clinical Trials Unit. His research interests include HIV biology, antiretroviral therapy and both basic and clinical pharmacology of HIV drugs.

Michael M. Lederman, MD is the Scott R. Inkley Professor of Medicine and Professor of Molecular Biology/Microbiology, Pathology and Biomedical Ethics at the Case Western Reserve University (CWRU) in Cleveland where he is director of the Center for AIDS Research.  He is a member of the American Association of Immunologists, the Infectious Diseases Society of America, and the HIV Medicine Association. His research interest is in the mechanisms of immune deficiency, immune restoration, and prevention of HIV infection.

Guido Silvestri, MD is an Associate Professor of Pathology & Laboratory Medicine at the Hospital of the University of Pennsylvania, where he also serves as Director of Clinical Virology. Dr. Silvestri directs an NIH-funded research laboratory that conducts studies of AIDS pathogenesis and vaccines. In particular, Dr. Silvestri's work has elucidated the mechanisms by which SIV infection of natural hosts is not followed by progression to AIDS, thus providing important insights on how HIV infection causes immunodeficiency in humans. Dr. Silvestri serves as consultant for the AIDS research programs of the US, French and Canadian governments.

PhD Mark A. Wainberg is Director of the McGill University AIDS Centre and Professor of Medicine and of Microbiology at McGill University in Montreal, Canada. Dr. Wainberg, an internationally recognized scientist in the field of HIV/AIDS, has made many contributions to the study of the reverse transcriptase (RT) of HIV-1 in regard to basic mechanisms of action, inhibition by anti-viral drugs, drug resistance, and HIV replication. He served as President of the International AIDS Society between 1998 and 2000 and was Co-Chair of the XVI International AIDS Conference in 2006.